Evidence map›Paper›PMID 37162366›Full record

ArticleJournal of bacteriology2023

The Streptococcus agalactiae Exonuclease ExoVII Is Required for Resistance to Exogenous DNA-Damaging Agents.

P Briaud, T Gautier, V Rong, L Mereghetti, P Lanotte, A Hiron

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of bacteriology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. DNA repair is essential forJournal of bacteriology · 2025
    Article
  3. DNA repair is essential forbioRxiv : the preprint server for biology · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

P Briaud *Université de Tours, INRAE, ISP, Tours, France.
T Gautier *Université de Tours, INRAE, ISP, Tours, France.
V RongUniversité de Tours, INRAE, ISP, Tours, France.
L MereghettiUniversité de Tours, INRAE, ISP, Tours, France.
P LanotteUniversité de Tours, INRAE, ISP, Tours, France.ORCID 0000-0002-9993-5548
A HironUniversité de Tours, INRAE, ISP, Tours, France.
Université de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus agalactiae is a human pathogen responsible for severe invasive infections in newborns. In this bacterium, XseB, a part of the ExoVII exonuclease, was shown to be specifically more abundant in the hypervirulent ST-17 strains. In Escherichia coli, ExoVII is associated either with mismatch repair or with recombinational DNA repair and is redundant with other exonucleases. In this study, the biological role of S. agalactiae ExoVII was examined. The Δ

Indexed as

Escherichia coli ProteinsBacterial ProteinsDNA RepairEscherichia coliExodeoxyribonucleasesHumansInfant, NewbornStreptococcus agalactiaeBacterial ProteinsEscherichia coli ProteinsExodeoxyribonucleasesDNA repairexonucleaseStreptococcus agalactiae

Identifiers

PMID37162366
PMCPMC10294681
OpenAlexW4376117852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.